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The JeffCare Preceptor Model for Asthma: 
A Primary Care Physician Tutorial Training Model
JEFFREY L. LENOW, M.D., J.D.,1,2 ROBERT BALES, M.D., M.P.H.,3
and STANTON N. SMULLENS, M.D.4,5,6
ABSTRACT
The societal and economic impact of asthma is a well-documented phenomenon in this coun-
try. Despite improved knowledge and techniques of care, there have been signs of worsen-
ing morbidity/mortality and a seeming disconnect between physician and patients as regards
communication of care strategies. In an attempt to fashion innovative educational strategies
to enhance primary care physician (PCP) and caregiver efficiencies in improving patient out-
comes (clinical and financial), the “Preceptor” model of one-to-one PCP/asthma specialist has
been developed. Review of utilization and prescribing data demonstrates a clear pattern of
statistically significant cost improvement in the aggregate care setting, as well as improved
appropriateness of use of proper asthma medications. Use of the “Preceptor” model of PCP
learning is an effective and unique way to enhance both caregiver knowledge and improved
care efficiency in asthma management.
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INTRODUCTION
CLINICAL IMPROVEMENT will derive from abalanced perspective of both quality and
cost. The industry of disease management 
offers flexible approaches that can enable in-
novative and low-cost strategies to help oper-
ationalize improvement. Certainly, the em-
ployer industry, which pays a significant
portion of health premiums, has begun to make
its voice heard by way of the Leapfrog initia-
tive,1 and the industry as a whole has been pro-
foundly influenced to focus on quality im-
provement initiatives to enhance patient safety
and reduce medication errors.2,3 We are ag-
gressively entering what can properly be
termed the “era of accountability” in the health
care delivery industry, where evidence-based
problem solving strategies are fast becoming
determinants of success and failure for practi-
tioners and health care systems.4 The emer-
gence of the disease management discipline has
offered opportunities to design innovative new
learning methodologies for caregivers on the
“front lines” of medicine, the primary care
physicians (PCPs), to address identified gaps
in the physician–patient educational nexus.5
Creating such models for PCPs is challenging
given the lack of time today’s practitioners
have available for extraneous learning activi-
ties. Yet, reliance on traditional models of con-
tinuing learning may be insufficient for mod-
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ical College of Thomas Jefferson University; 2Medical Director and 4CEO, JeffCare, Inc. (Physician Hospital Organi-
zation for Thomas Jefferson University Hospital and affiliated physician network), Philadelphia, Pennsylvania.
3Department of Family Medicine, The Bryn Mawr Hospital, Bryn Mawr, Pennsylvania.
6Chief Medical Officer, Jefferson Health System, Radnor, Pennsylvania.
ern learners, and the movement toward inter-
active and case-based models of continuing ed-
ucation is being demonstrated to have a more
effective impact.6
Jefferson Medical College of Thomas Jeffer-
son University in Philadelphia, PA has thus
partnered with its physician hospital organiza-
tion, JeffCare, Inc., to define such a new model
of learning for its primary care network utiliz-
ing what we call the “Preceptorship” program.
(JeffCare, Inc., is a wholly owned subsidiary of
Thomas Jefferson University Hospital, respon-
sible for network development and managed
care contracting.) The primary focus of this pro-
gram has been on asthma education and man-
agement. In Philadelphia, it has long been ob-
served that there is a significant prevalence of
asthma, especially in the inner city metropoli-
tan service area of Thomas Jefferson University
Hospital, with a disproportionate rate of deaths
from this disease.7 Lang and Polansky8 noted
that the rates of death from asthma have in-
creased in Philadelphia, whereas concentra-
tions of major air pollutants have declined
within particular problem areas affecting the
minority, poor, and African American popula-
tions. Clearly, improving educational ap-
proaches in asthma care for the front-line PCP
caregivers is a compelling need.
An additional reason to pursue more effec-
tive modalities of provider education comes
with the recognition that the cost of care from
chronic asthma illness continues to rise.9 In
2000, the then Surgeon General, David Satcher,
M.D., revealed data demonstrating a dramatic
rise in cases of asthma over the last 15 years re-
flecting in the increasing drain on the U.S. econ-
omy: from $4.5 billion in 1985 to $10.7 billion
in 1994.10 Estimates, of course, will vary based
on the estimating methodology used. In a Cen-
ters for Disease Control and Prevention publi-
cation in the year 2000, direct and indirect costs
associated with asthma during 1998 were an 
estimated $12.7 billion.11 Smith et al12 noted
asthma cost breakdown as follows: office vis-
its, 12%; hospital outpatient visits, 11%; emer-
gency room, 6.8%; hospitalization, 54.4%.
Clearly, given the societal and economic sig-
nificance of this disease process, new models
of caregiver education are warranted. Of spe-
cial concern is the trend toward increasing
prevalence of asthma in our market area of
metropolitan Philadelphia, which includes a
large inner city population. Currently, nearly
one out of 13 persons in southeastern Penn-
sylvania (7.4%, or 274,300 persons) report hav-
ing asthma, representing 185,000 adults (6.6%)
and 89,000 children (10.0%). The percentage of
all persons with asthma in southeastern Penn-
sylvania has increased over 40% in the past
decade. In 1991, 5.2% of persons had asthma
compared with 7.4% in 2000.13
PROGRAM DESCRIPTION/METHODS
The Jefferson Health System is an integrated
delivery system comprising several hospital
systems in the tri-state metropolitan Philadel-
phia region. It includes the Albert Einstein
Health Network, Frankford Healthcare System,
Main Line Health System, Thomas Jefferson
University Hospital, and Magee Rehabilitation
Center and their various affiliates. It serves ap-
proximately 26% of the nearly 6 million living
in the region and has approximately 750 PCPs
and over 2,500 specialists in its various system
networks.
The premise of our “preceptor model” fo-
cuses on matching a single PCP-learner with a
disease specialist for a half-day session. PCPs
affiliated with the Jefferson Health System
were invited to participate in a continuing ed-
ucation program for asthma management. The
two physicians work together, seeing patients
and discussing primary care “pearls” of asthma
care. In addition to the physician preceptor-
ship, the office staff of each physician-learner
received an in-service session by a professional
asthma nurse practitioner in the use of an
asthma “plan,” metered dose inhaler tech-
nique, and proper use of the peak flow meter.
The purpose of this additional feature was to
ensure that patients of the PCP-learners would
receive appropriate asthma education.
Both PCP-learners and preceptors were fi-
nancially compensated for their time (typically
a $350 honorarium per physician for a half-day
session, distributed by JeffCare, Inc.). The re-
sults reviewed include data from asthma
claims (inpatient, outpatient, emergency room)
for the year 1999, which preceded the inter-
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vention program. This was compared with
claims collected post-intervention in the year
2000. Participant PCP-learners were drawn
from the entire Jefferson Health System net-
work of PCPs. Letters of explanation and invi-
tation were faxed on multiple occasions, as well
as “direct detailing” visits by our clinical man-
agement and provider relations personnel. In
this initial program recruitment effort, there
were no attempts to preselect participants
based on prior utilization behaviors or cost pro-
files. PCP-learners were included in this pro-
gram based on their expressed interest in par-
ticipating. The JeffCare, Inc., staff facilitated
appointments, and asthma specialists in the
system were matched with interested PCP-
learners. Preceptor faculty were instructed to
review the various diagnostic and treatment
guidelines as supported by the National Insti-
tutes of Health guidelines for asthma.14
JeffCare, Inc., as a physician hospital organi-
zation, has been involved in a full risk-based
insurance product since 1997. The significance
of participation in such a full-risk percentage
of premium arrangement is noteworthy as such
arrangements allow for very reliable captive
claims data by the risk-bearer, in this case Jef-
ferson University Hospital’s managed care di-
vision, JeffCare, Inc. JeffCare’s risk arrange-
ment was a full assignment of risk for which
the health system bore total exposure for losses
and catastrophic claims. Many other health sys-
tems in the United States have engaged in “par-
tial” or lesser risk arrangements with managed
care partners. Full-risk arrangements, if noth-
ing else, allow the holder of risk a legitimate
access to the claims activity for which they
were involved. This enables a reasonable cate-
gorization of data outcomes for this review.
Claims data relating to asthma care were re-
viewed retrospectively in an attempt to com-
pare utilization data for 2 successive years’
worth of claims. In essence, we were able to
view costs and utilization for a given physi-
cian/practice before and after the preceptor-
ship intervention. Data were culled in the ag-
gregate from the JeffCare, Inc., database from
its risk-based population of patients. These pa-
tient claims are from patients cared for by our
physician-learners in this project. The prepaid
capitation amounts were not factored into the
cost/utilization evaluation, as there was no
clear way to segregate that portion of capita-
tion that would apply to asthma-related care.
Owing to changes in plan participation, only
the 32 PCP-learners directly affiliated with 
JeffCare, Inc., were studied for this analysis.
While we have trained approximately 140 PCP-
learners in the entire Jefferson Health System
to date, only PCP-learners for whom we had
risk-based data both pre- and post-learning in-
tervention were included in the summary re-
view in this article. Not every member of the
Jefferson Health System hospital consortium
was actively a part of the risk-based contract at
the start of this intervention, and thus the reli-
ability of pre- and post-intervention data
would not be as firm as the included subset of
PCP-learners used for this analysis. The Jeff-
Care, Inc.-based physicians are spread across
25 capitated offices in southeastern Pennsylva-
nia and southern New Jersey. Data from Feb-
ruary 1, 1998 to June 22, 2001 were extracted
from the entire claims database. Claims data for
the 25 capitated offices were extracted from the
larger data set. Only claims that carried a pri-
mary diagnosis code for asthma (ICD-9: 493.0,
493.1, 493.9) were included. Claims studied
were for 1 year beginning from the date of the
preceptorship intervention as compared with 1
year’s worth of data prior to the intervention.
Outcomes used were actual paid amounts,
and hospital bed days. These outcomes were
grouped into two categories based on the date
the PCP participated in the education program.
Therefore, each physician is his/her own con-
trol. Student’s t test was employed as the test
of significance, with a critical p value of 0.05.
Subgroups were examined based on age, gen-
der, and site of care delivery. Data were com-
piled using Microsoft Access 97 and were ana-
lyzed with SPSS version 7.5.3.0 for Windows
from SPSS, Inc.
RESULTS
Pharmaceutical utilization patterns in study group
While the initial set of data (Table 1) observes
potential impact of the intervention model on
certain utilization categories, Tables 2 and 3
look at potential pharmaceutical prescribing
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impact that might relate to this intervention
model.
In an attempt to evaluate impact on pre-
scribing behaviors as a result of the preceptor-
ship intervention, proprietary pharmaceutical
industry data were accessed representing por-
tions of eastern Pennsylvania, central and
southern New Jersey, and portions of Delaware
(NDC Health Information Services [Arizona],
Inc.). This allowed comparison of the JeffCare,
Inc., participants with regional prescribers who
had not had similar preceptorship experience.
All data for Table 2 used new prescription
counts between August 1999 and August 2000.
The categories are defined as follows: asthma
controller segment (Intal® [Fisons], Tilade®
[Fisons], Aerobid® [Forest], Azmacort®
[Rhone-Poulenc Rorer], Flovent® [Glaxo],
Qvar® [3M Riker], Vanceril® [Schering], Atro-
vent® Inhalation Aerosol [Boehringer Ingel-
heim], Combivent® [Boehringer Ingelheim],
Foradil® [Ciba-Geigy], Serevent® [Glaxo], Ac-
colate® [ICI], Singulair® [Merck & Co.], Zyflo®
[Abbott], Pulmicort® [Astra], Beclovent®
[Glaxo]); total ICS (Aerobid® [Forest], Azma-
cort, Flovent, Qvar, Vanceril, Pulmicort, Beclo-
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TABLE 1. CLAIMS DATA FOR JEFFCARE, INC., PCP-LEARNERS
n Mean paid amount p Total Paid bed days1 p Total
Total
Pre 691 $160.08 0.015 $110,615.28 0.1158 0.04 80.02
Post 931 $75.23 $70,039.13 0.0591 55.02
Males
Pre 293 $105.76 0.549 $30,987.68 0.0819 0.762 24.00
Post 356 $84.52 $30,089.12 0.0702 24.99
Females
Pre 398 $200.07 0.014 $79,627.86 0.1407 0.023 56.00
Post 575 $69.47 $39,945.25 0.0522 30.02
Children (,18 years)
Pre 197 $74.01 0.007 $14,579.97 0.1066 0.02 21.00
Post 399 $46.71 $18,637.29 0.0602 24.02
Adults ($18 years)
Pre 494 $194.41 0.071 $96,038.54 0.1194 0.113 58.98
Post 532 $96.61 $51,396.52 0.0583 31.02
Outpatient/office
Pre 559 $42.85 0.015 $23,953.15
Post 787 $50.42 $39,680.54
Emergency
Pre 57 $146.32 0.084 $8,340.24
Post 71 $90.32 $6,412.72
Inpatient
Pre 75 $1,044.31 0.048 $78,323.25 1.07 0.245 80.25
Post 73 $327.94 $23,939.62 0.75 54.75
1The bed days column represents the mean number of inpatient days per person over the time period. The 
total column is the mean 3 n.
TABLE 2. PRESCRIBING PATTERNS OF PCP PARTICIPANTS
Eastern Pa NJ DE region JeffCare participants
August August % August August %
1999 2000 change 1999 2000 change
Asthma controller 259,928 292,578 13% 1,626 1,948 20%
Total ICS 135,594 145,385 7% 909 1,024 13%
Asthma relief 288,220 286,736 21% 2,063 1,858 210%
ICS, inhaled corticosteroid.
vent); and asthma relief (albuterol, Maxair®
[3M Riker], Proventil® [Schering], Ventolin®
[Allen & Hanburys]).
Table 3 looks at the comparison of the Jeff-
Care Learner group against their own pre-
scribing behaviors over 2 years of observation.
Analysis
Table 1 reflects statistically significant sup-
port for the observation that total asthma care
costs (outpatient and inpatient) for the sample
of PCP-learners reviewed demonstrates an
overall savings of about $40,500 for the time pe-
riod studied. In a breakdown analysis by cate-
gories including sex, age, as well as loca-
tion/type of service, findings are consistent
with the fact that participant-learners experi-
enced a change in utilization behaviors follow-
ing the preceptor experience.
Outpatient care costs increased post-inter-
vention, signaling the likelihood of PCP-learn-
ers using a greater amount of outpatient 
services secondary to their preceptorship ex-
perience. Yet, inpatient costs for this group
were dramatically reduced by a total of almost
$55,000.
In the review of pharmaceutical use (Table
2), the comparisons against regional use pat-
terns are noteworthy (NDC Health Information
Services [Arizona], Inc.). While the total ICS
utilization for the regional group increased by
7% from 1999 to 2000, the Jefferson group
showed a 13% overall increase post-interven-
tion. Similarly, rescue therapy for the regional
group dropped by 1%, whereas the Jefferson
group showed a 10% drop. These are positive
trends for the intervention group studied, as it
was hoped that these patterns would manifest
after formal preceptor education, and certainly
consistent with the patterns manifested in uti-
lization data in Tables 1 and 2.
Figure 1 (a graphical depiction of data in
Table 3) is a review of the JeffCare, Inc., PCP-
learners group comparing prescribing behav-
iors for the 1999 pre-intervention period with
post-intervention segments for both years 2000
and 2001. Categories include total asthma con-
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TABLE 3. JEFFCARE LEARNERS COMPARISON OF ASTHMA PRESCRIBING HABITS FOR 1999 VERSUS 2000 AND 2001
August 1999 August 2000 p August 1999 August 2001 p
Asthma controller1 31.88 38.20 0.023 31.88 51.39 0.00006
ICS 17.82 20.08 0.142 17.82 22.78 0.04138
LTM 5.84 8.63 0.007 5.84 11.12 0.00844
SABA1 40.45 36.43 0.102 40.45 34.33 0.09651
Data are from NDC Health Information Services (Arizona), Inc. LTM, leukotriene agents; SABA, short-acting
beta-agonists.
1New prescriptions.
FIG. 1. JeffCare learners comparison of asthma prescribing habits for 1999 versus 2000 and 2001. *New prescriptions.
trollers, ICS, LTM, and SABA. This demon-
strates a clear improvement in behaviors by the
PCP-learners who participated in the precep-
tor program in their use and prescribing of
asthma controllers, with an overall decrease in
the use of rescue therapy medications, and an
increase in the use of ICSs.
STUDY CRITICISMS
Unquestionably, the program was first de-
signed solely as an innovative instructional
model to promote improved primary care
asthma intervention by our network of PCPs.
Consideration of a formal patient study model
was not the driving force behind this program.
Nonetheless, care was taken subsequent to pro-
gram implementation to cull data that were 
statistically valid in the comparison areas of in-
terest. However, since the guidelines for pre-
ceptors were fairly “open-ended” and subject
to variable interpretation, each PCP-learner
may have had varying emphasis based on the
bias of the preceptor involved. This can be con-
trolled somewhat in future iterations by a more
formalized and regimented structured set of
minimal requirements for items a preceptor
must include in a given session.
In attempting to define “value” to the pro-
gram by the review of claims-based informa-
tion, we readily acknowledge the difficulty in
assigning hard savings as compared with the
actual cost of running the program. We used a
reliable “n” of PCP-learners who were in the
full-risk program throughout the preceptor 
intervention time frame, and we reported a
savings accordingly based on this number.
Whether this can be extrapolated to the larger
group of learners is pure conjecture. The true
cost of the program to JeffCare, Inc., is small
for no other reason than that we utilized staff
already employed for various other physician
hospital organization functionalities. Addi-
tional costs to JeffCare, Inc., would mainly be
administrative time, office-based materials,
phones, and the like. We did not attempt to
configure these costs as part of the program,
but suspect the amounts would not be signifi-
cant under our particular framework of opera-
tions.
An additional question could be raised about
the potential for “spillover” effect on practices
impacted upon by the PCP-learner involve-
ment and his/her staff’s involvement with the
in-service program. This was not a part of the
scope of this particular effort, though worthy
of future consideration in additional studies of
this nature.
A significant program modification in the
preceptorship model begins in early 2003. It
will include the employ of professionally
trained “standardized patients” in which PCP-
learners will interview three or four special
case studies in person and then be debriefed by
one of our asthma specialists on campus. This
should provide for a more uniform experience,
easier evaluative feedback from our learners,
and an ability to more efficiently utilize grant
funds to train a larger number of participants.
We also have engaged in a new “partner-
ship” model we call the “Triangular Partner-
ship.” Future preceptor programs will now in-
clude not only a Pharma industry partner, but
also a managed care entity. In so doing, we will
have more controlled and timely claims data
analysis capabilities (clearly a constraint in this
study as we were limited to a smaller “n” of
participants for our own captive risk data). We
are currently in the start of one such program
(start date September 2002) and expect to be-
gin a second “Triangular Partnership” in De-
cember 2002/January 2003. This additional
“partner” brings significant value to future
studies in terms of the availability of claims
data that will not always be available in such
efforts given the reduction of “risk assump-
tion” models by health care systems in the near
future.
An additional criticism can center on the va-
lidity of concluding that there is a “cause and
effect” relationship between the utilization
data and the fact that these participants were
involved in such a program. There may indeed
be other variables responsible for these out-
comes that this evaluation cannot take into full
account. Finally, the study does not account for
patient satisfaction or quality of life change pre-
and post-intervention. The study size required
for this analysis was beyond the scope and re-
source of this effort, but such evaluative tools
are available and well tested.15
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DISCUSSION
The influence of local medical opinion lead-
ers in the approach to innovative models of
learning for PCPs is well demonstrated.16 We
are of the view that combining the preceptor-
ship experience with the nurse practitioner pa-
tient-training lessons for office staff offers the
optimal training intervention for our network
PCP-learners. We believe it will help to address
one of the biggest challenges in asthma man-
agement, the noncompliant patient.17 In ad-
dressing the special needs of our inner city pop-
ulation, where asthma management can be
most challenging, recognition of the fact that
there is significant underuse of ICSs (despite
admonitions from the National Institutes of
Health asthma guidelines) and a greater need
to impact the education of this population fur-
ther underscores the importance of this ap-
proach.18 As noted in the self-critique, a “cause
and effect” impact on propriety of asthma con-
trolling agent prescribing is, at best, inferred.
However, a pattern is suggested that warrants
larger studies with a more direct tie to patient
participation and involvement. If the “Precep-
torship” model does lend toward a greater ap-
propriateness of use of ICSs and decreased use
of rescue therapies, then this interactive ap-
proach to physician education warrants further
evaluation.19
CONCLUSION
The JeffCare preceptor model offers an in-
novative and interactive alternative to tradi-
tional continuing medical education-based di-
dactic lecture format for continuing education
of PCP-learners. The opportunity for inter-
industry partnership is an attractive feature of
the model, and physicians favor the informal-
ity of the one-to-one interaction with an asthma
specialist. Preliminary claims data, as well as
prescribing patterns in pre- and post-interven-
tion years, suggest a possible relationship be-
tween this focused training model and im-
proved utilization and more appropriate
prescribing patterns. Use of the “standardized
patient” model as well as pre- and post-physi-
cian-learner surveys for self-assessment of 
preparedness for primary asthma care man-
agement issues will be necessary in future it-
erations of this program.
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